These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 27959394)

  • 1. miR-214 suppresses the osteogenic differentiation of bone marrow-derived mesenchymal stem cells and these effects are mediated through the inhibition of the JNK and p38 pathways.
    Guo Y; Li L; Gao J; Chen X; Sang Q
    Int J Mol Med; 2017 Jan; 39(1):71-80. PubMed ID: 27959394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icariin induces osteogenic differentiation of bone mesenchymal stem cells in a MAPK-dependent manner.
    Wu Y; Xia L; Zhou Y; Xu Y; Jiang X
    Cell Prolif; 2015 Jun; 48(3):375-84. PubMed ID: 25867119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulative Effect of Mir-205 on Osteogenic Differentiation of Bone Mesenchymal Stem Cells (BMSCs): Possible Role of SATB2/Runx2 and ERK/MAPK Pathway.
    Hu N; Feng C; Jiang Y; Miao Q; Liu H
    Int J Mol Sci; 2015 May; 16(5):10491-506. PubMed ID: 25961955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR‑217 inhibits osteogenic differentiation of rat bone marrow‑derived mesenchymal stem cells by binding to Runx2.
    Zhu YL; Wang S; Ding DG; Xu L; Zhu HT
    Mol Med Rep; 2017 May; 15(5):3271-3277. PubMed ID: 28339007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mir-150-5p inhibits the osteogenic differentiation of bone marrow-derived mesenchymal stem cells by targeting irisin to regulate the p38/MAPK signaling pathway.
    Qi JL; Zhang ZD; Dong Z; Shan T; Yin ZS
    J Orthop Surg Res; 2024 Mar; 19(1):190. PubMed ID: 38500202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [REGUL ATORY EFFECT OF SIMVASTATIN ON MIDDLE/L ATE STAGES OSTEOGENIC DIFFERENTIATION OF BONE MARROW MESENCHYMAL STEM CELLS VIA p38MAPK PATHWAY].
    Zhang K; Liu G; Tian F; Zhang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Aug; 30(8):1038-1043. PubMed ID: 29786238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bone morphogenetic protein-2 in osteogenic differentiation of mesenchymal stem cells.
    Sun J; Li J; Li C; Yu Y
    Mol Med Rep; 2015 Sep; 12(3):4230-4237. PubMed ID: 26096280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypeptides IGF-1C and P24 synergistically promote osteogenic differentiation of bone marrow mesenchymal stem cells in vitro through the p38 and JNK signaling pathways.
    Ran G; Fang W; Zhang L; Peng Y; Wu A; Li J; Ding X; Zeng S; He Y
    Int J Biochem Cell Biol; 2021 Dec; 141():106091. PubMed ID: 34624508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vibration loading promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells via p38 MAPK signaling pathway.
    Lu Y; Zhao Q; Liu Y; Zhang L; Li D; Zhu Z; Gan X; Yu H
    J Biomech; 2018 Apr; 71():67-75. PubMed ID: 29503016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-23b targets Smad 3 and ameliorates the LPS-inhibited osteogenic differentiation in preosteoblast MC3T3-E1 cells.
    Liu H; Hao W; Wang X; Su H
    J Toxicol Sci; 2016 Apr; 41(2):185-93. PubMed ID: 26961602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing effects of myricetin on the osteogenic differentiation of human periodontal ligament stem cells via BMP-2/Smad and ERK/JNK/p38 mitogen-activated protein kinase signaling pathway.
    Kim HY; Park SY; Choung SY
    Eur J Pharmacol; 2018 Sep; 834():84-91. PubMed ID: 30012495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. αCGRP Regulates Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Through ERK1/2 and p38 MAPK Signaling Pathways.
    Jiang Y; Xin N; Xiong Y; Guo Y; Yuan Y; Zhang Q; Gong P
    Cell Transplant; 2022; 31():9636897221107636. PubMed ID: 35758252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-206 inhibits osteogenic differentiation of bone marrow mesenchymal stem cells by targetting glutaminase.
    Chen Y; Yang YR; Fan XL; Lin P; Yang H; Chen XZ; Xu XD
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30804229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral trioxide aggregate upregulates odonto/osteogenic capacity of bone marrow stromal cells from craniofacial bones via JNK and ERK MAPK signalling pathways.
    Wang Y; Li J; Song W; Yu J
    Cell Prolif; 2014 Jun; 47(3):241-8. PubMed ID: 24635197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-magnitude vibration induces osteogenic differentiation of bone marrow mesenchymal stem cells via miR-378a-3p/Grb2 pathway to promote bone formation in a rat model of age-related bone loss.
    Yu X; Zeng Y; Bao M; Wen J; Zhu G; Cao C; He X; Li L
    FASEB J; 2020 Sep; 34(9):11754-11771. PubMed ID: 32652777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MEG3 inhibited osteogenic differentiation of bone marrow mesenchymal stem cells from postmenopausal osteoporosis by targeting miR-133a-3p.
    Wang Q; Li Y; Zhang Y; Ma L; Lin L; Meng J; Jiang L; Wang L; Zhou P; Zhang Y
    Biomed Pharmacother; 2017 May; 89():1178-1186. PubMed ID: 28320084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic acetal hydroxyapatite composites and endogenous osteogenic gene expression of rat marrow stromal cells.
    Patel M; Dunn TA; Tostanoski S; Fisher JP
    J Tissue Eng Regen Med; 2010 Aug; 4(6):422-36. PubMed ID: 20047194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
    Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
    Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic fibroblast growth factor lentiviral vector-transfected sheep bone marrow mesenchymal stem cells and non-specific osteogenic gene expression.
    Hu Y; Zhang Q; Zhang L; Tang XX; He HY
    Mol Med Rep; 2015 Jul; 12(1):267-72. PubMed ID: 25738986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK inactivation suppresses osteogenic differentiation, but robustly induces osteopontin expression in osteoblasts through the induction of inhibitor of DNA binding 4 (Id4).
    Kusuyama J; Amir MS; Albertson BG; Bandow K; Ohnishi T; Nakamura T; Noguchi K; Shima K; Semba I; Matsuguchi T
    FASEB J; 2019 Jun; 33(6):7331-7347. PubMed ID: 30884976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.